Lawrence Lamb is EVP and CSO at IN8BIO, INC. (INAB). They have made 1 open-market trade across 1 company since 2022, most recently 2023-12-13.
CIK 0001830059
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $999 since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INAB | 101,369 | $108K |
Shares reported on the most recent Form 4, priced at the 2023-12-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INAB | BUY | 2022-08-16 | 2022-08-18 | $1.90 | $999 | +45.3% | +28.9% | -19.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.